Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer Journal Article


Authors: Dikken, J. L.; van Grieken, N. C. T.; Krijnen, P.; Gonen, M.; Tang, L. H.; Cats, A.; Verheij, M.; Brennan, M. F.; Van de Velde, C. J. H.; Coit, D. G.
Article Title: Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer
Abstract: Background: While it is suggested that more than 15 lymph nodes (LNs) should be evaluated for accurate staging of gastric cancer, LN yield in western countries is generally low. The effect of preoperative chemotherapy on LN yield in gastric cancer is unknown. The aim of the present study is to determine whether preoperative chemotherapy is associated with any difference in the number of LNs obtained from specimens of patients who underwent curative surgery for gastric adenocarcinoma. Patients and Methods: In 1205 patients from Memorial Sloan-Kettering Cancer Center (MSKCC) and 1220 patients from the Netherlands Cancer Registry (NCR) who underwent a gastrectomy with curative intent for gastric adenocarcinoma without receiving preoperative radiotherapy, LN yield was analyzed, comparing patients who received preoperative chemotherapy and patients who received no preoperative therapy. Results: Of the 2425 patients who underwent a gastrectomy, 14% received preoperative chemotherapy. Median LN yields were 23 at MSKCC and 10 in the NCR. Despite this twofold difference in LN yield between the two populations, with multivariate Poisson regression, chemotherapy was not associated with LN yield of either population. Variables associated with increased LN yield were institution, female sex, lower age, total (versus distal) gastrectomy and increasing T-stage. Conclusions: In this patient series, treatment at MSKCC, female sex, lower age, total gastrectomy and increasing primary tumor stage were associated with a higher number of evaluated LNs. Preoperative chemotherapy was not associated with a decrease in LN yield. Evaluating more than 15 LNs after gastrectomy is feasible, with or without preoperative chemotherapy. © 2011 Elsevier Ltd. All rights reserved.
Keywords: adult; cancer chemotherapy; controlled study; aged; cancer surgery; major clinical study; cisplatin; fluorouracil; cancer patient; cancer staging; netherlands; poisson distribution; cancer center; folinic acid; lymph node; clinical evaluation; gastrectomy; cancer registry; preoperative treatment; stomach adenocarcinoma; stomach neoplasms; lymphography; drug therapy stomach neoplasms; surgery neoadjuvant therapy lymph nodes pathology
Journal Title: European Journal of Surgical Oncology
Volume: 38
Issue: 4
ISSN: 0748-7983
Publisher: Elsevier Inc.  
Date Published: 2012-04-01
Start Page: 319
End Page: 325
Language: English
DOI: 10.1016/j.ejso.2011.12.016
PROVIDER: scopus
PUBMED: 22261085
DOI/URL:
Notes: --- - "Export Date: 2 April 2012" - "CODEN: EJSOE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan
  2. Mithat Gonen
    1030 Gonen
  3. Johannes Leen Dikken
    11 Dikken
  4. Laura Hong Tang
    447 Tang
  5. Daniel Coit
    542 Coit